5DMG image
Deposition Date 2015-09-08
Release Date 2015-12-16
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5DMG
Keywords:
Title:
X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RB86 antibody Fab fragment he
Chain IDs:A (auth: H), C, E
Chain Length:211
Number of Molecules:3
Biological Source:Oryctolagus cuniculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RB86 antibody Fab fragment li
Chain IDs:B (auth: L), D, F
Chain Length:219
Number of Molecules:3
Biological Source:Oryctolagus cuniculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Microtubule-associated protei
Chain IDs:G (auth: Z), H (auth: P), I (auth: X)
Chain Length:15
Number of Molecules:3
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP G SER modified residue
Primary Citation
VH-VL orientation prediction for antibody humanization candidate selection: A case study.
Mabs 8 288 305 (2016)
PMID: 26637054 DOI: 10.1080/19420862.2015.1117720

Abstact

Antibody humanization describes the procedure of grafting a non-human antibody's complementarity-determining regions, i.e., the variable loop regions that mediate specific interactions with the antigen, onto a β-sheet framework that is representative of the human variable region germline repertoire, thus reducing the number of potentially antigenic epitopes that might trigger an anti-antibody response. The selection criterion for the so-called acceptor frameworks (one for the heavy and one for the light chain variable region) is traditionally based on sequence similarity. Here, we propose a novel approach that selects acceptor frameworks such that the relative orientation of the 2 variable domains in 3D space, and thereby the geometry of the antigen-binding site, is conserved throughout the process of humanization. The methodology relies on a machine learning-based predictor of antibody variable domain orientation that has recently been shown to improve the quality of antibody homology models. Using data from 3 humanization campaigns, we demonstrate that preselecting humanization variants based on the predicted difference in variable domain orientation with regard to the original antibody leads to subsets of variants with a significant improvement in binding affinity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback